Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system.

BACKGROUND: This retrospective study analysed the effects of preoperative and intraoperative factors on the occurrence of inotropic support after cardiopulmonary bypass (CPB). METHODS: The data sets of 1471 adult patients having received elective cardiac surgery with CPB were recorded using an online anaesthesia record-keeping system. Patients were judged to have required inotropic drug support if they had received one or a combination of the positive inotropic drugs, epinephrine, dobutamine and enoximone. The effects of age, height, weight, body mass index, gender, chronic heart failure, documented preoperative myocardial infarction, left main coronary artery disease, preoperative history of hypertension, chronic renal failure, diabetes mellitus, chronic obstructive pulmonary disease (COPD), preoperative medical treatment, type of surgical procedure, duration of CPB, duration of aortic clamping and reperfusion time were analysed by logistic regression for predictive power of the need for positive inotropic drugs. RESULTS: Of the patients, 32.4% received positive inotropic drugs in the operating theatre after weaning from CPB. The overall 30-day mortality was 2.2%. Of non-survivors, 81.8% received inotropes compared with 18.2% of survivors (P < 0.01). The numbers of previous myocardial infarctions (odds ratio (OR), 2.01), congestive heart failures New York Heart Association class > 2 (OR, 1.85), COPD (OR, 1.85) and age > 65 yr (OR, 1.62), aortic cross clamping time of > 90 min (OR, 2.32) and coronary artery bypass surgery (OR, 0.43) all represented influential factors within the logistic regression model. CONCLUSION: The knowledge of these risk factors should be useful in increasing the anaesthetist's vigilance in those patients most at risk for inotropic support and in providing for more timely therapeutic intervention and optimizing anaesthesia management.

[Risk factors and frequency of adverse effects after autologous blood donation]. / Risikofaktoren und Häufigkeiten von Nebenwirkungen bei autologen Blutentnahmen.

OBJECTIVE: Autologous blood donation before elective surgery decreases the perioperative risk although donation itself can cause adverse effects. Are there specific donor characteristics, which influence the frequency and severity of adverse effects? METHODS: We investigated in a prospective study 3603 autologous blood donations including registration of patient's age, gender, height, weight, medical record and risk-score by Böcker. The adverse effects were divided into severity groups (SG). The investigation took place in a Department of Anaesthesiology and Intensive Care Medicine in an university hospital. 1041 patients with preoperative autologous blood donation were investigated between January 1995 and April 1997. RESULTS: 7.4% of patients had adverse effects. Hypotension and bradycardia were the most frequent adverse effects. 4.3% of the adverse effects were graded as minimal (SG 1), 2.4% as mild (SG 2) and 0.7% as moderate (SG 3). The rate was higher in young donors (< 25 years). For all other donor characteristics including older age, cardiac or pulmonary diseases and high risk-score no higher donation risk was observed. CONCLUSIONS: Adverse effects during and after autologous blood donation are rare. Predictor for reaction seems to be young age (< 25 years). Referring to donor's characteristics and predonation risk factors it is hardly possible to predict adverse effects. Thus, all autologous blood donors require adequate monitoring by a physician. Under these circumstances the autologous blood donation is a safe procedure even in patients with severe risk factors.